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Chronic hepatitis in the English springer spaniel: 
clinical presentation, histological description 
and outcome
N. H. Bexfield, C. Andres-Abdo, T. J. Scase, F. Constantino-Casas, 
P. J. Watson
Medical records and liver histology of 68 English springer spaniels (ESS) with a histological 
diagnosis of CH were reviewed retrospectively. PCR was performed on liver tissue for canine 
adenovirus-1 (CAV-1), canine parvovirus, canine herpesvirus and pathogenic Leptospira 
species. Follow-up information was obtained to calculate survival times. Median age at 
presentation was three years seven months (range, seven months to eight years five 
months) and there were 48 female and 20 male dogs. Clinical signs were non-specific and 
five dogs were asymptomatic. All dogs had an increase in serum activity of one or more 
hepatobiliary enzymes. Histopathology demonstrated hepatocyte necrosis and apoptosis 
with varying amounts of fibrosis. A predominantly lymphoplasmacytic infiltrate throughout 
the hepatic parenchyma was found in all 68 dogs, but 45 of these dogs also had a neutrophilic 
component to the inflammatory infiltrate. There was no significant copper accumulation and 
no aetiological agent was identified by PCR. The median survival time was 189 days (range, 
1 to 1211 days), 38 dogs died within three months and 12 dogs survived more than a year 
following diagnosis.
CANINE chronic hepatitis (CH) is characterised histologically by the 
presence of hepatocellular apoptosis or necrosis, a variable mononu-
clear or mixed inflammatory infiltrate, regeneration and fibrosis (Van 
den Ingh and others 2006). Several breeds of dog have been shown to 
be predisposed to the development of CH including the American and 
English cocker spaniel, West Highland white terrier, Scottish terrier, 
labrador retriever and dobermann (Andersson and Sevelius 1991). The 
disease is seen more commonly in middle-aged and older animals and 
a gender predisposition has been observed in several breeds.
Known causes of canine CH include the viruses CAV-1 (Chouinard 
and others 1998) and herpesvirus (Schulze and Baumgärtner 1998), 
bacteria including leptospires (Bishop and others 1979) and Helicobacter 
species (Fox and others 1996) and several toxins and drugs (Bunch 
1993). Breed-associated defects in copper metabolism have been 
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described. Other metabolic defects such as α1-antitrypsin deficiency 
have been linked to CH in the cocker spaniel (Sevelius and   others 
1994). Primary immune-mediated mechanisms have also been 
  suggested as a cause of canine CH but have never been conclusively 
demonstrated (Andersson and Sevelius 1992, Weiss and others 1995). 
The aetiology of CH in most dogs remains idiopathic (Poldervaart and 
others 2009).
We have recently reported on an increased prevalence of CH in the 
English springer spaniels (ESS) in the UK (Buxton and others 2009) 
although a detailed description of the disease has not been published. 
The aim of the current study was therefore to describe the history, 
clinical signs, clinicopathologic abnormalities, diagnostic imaging 
findings, histological appearance and outcome of ESSs with CH. The 
authors also aimed to investigate the role of potential aetiological 
  factors including copper and infectious agents.
Materials and methods
The study period was between June 2006 and September 2010. 
The study population consisted of ESSs presenting to the Queen’s 
Veterinary School Hospital (QVSH), Department of Veterinary 
Medicine, University of Cambridge, and additional cases. Details of 
these additional cases were obtained via contact with primary and 
referral practices within the UK. Cases were included when results of 
hepatic histology were consistent with a diagnosis of CH according to 
criteria developed by the World Small Animal Veterinary Association 
(WSAVA) Liver Standardization Group (Van den Ingh and others 
2006), when complete case records were available and if the outcome 
could be assessed either from the case records or by contact with the 
owner or veterinary surgeon. Data obtained included signalment, 
clinical signs, physical examination findings, results of laboratory tests 
and imaging. Laboratory data examined included serum biochemis-
try, complete blood count and coagulation times. Serum biochemistry Veterinary Record | October 15, 2011
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ferent genes of the different fam-
ily members using commercially 
available software (ClustalW; 
EMBL-EBI). Gene sequences 
were retrieved from the GenBank 
sequence database, National 
Centre for Biotechnology 
Information (NCBI). Primers 
for the detection of pathogenic 
Leptospira species were as previ-
ously published (Fearnley and 
others 2008). Primers were 
checked for secondary structure 
and primer-dimers. All primer 
sequences are given in T able 
1. Positive controls for CAV-1, 
canine parvovirus and Leptospira 
PCR consisted of DNA extracted 
from fresh frozen liver tissue from 
infected canine cases. Positive 
control for canine herpesvirus 
PCR consisted of DNA extracted 
from archived canine herpesvirus 
grown in cell culture. As a nega-
tive control, water was used as a 
template for each PCR reaction. 
Amplification was performed 
using 2 μl of extracted DNA, 0.2 
μM of each primer, 1.25 units 
DNA polymerase (GoT aq DNA 
polymerase; Promega), 50 mM 
Tris-HCl (pH 9.0), 50 mM NaCl, 3.0 mM MgCl2, 0.2 mM of each 
dNTP and distilled water to a final volume of 50 μl. After a single dena-
turation step at 95°C for two minutes, 35 cycles of amplification were 
performed in a thermal cycler (Bio-Rad iCycler; Bio-Rad Laboratories). 
Each cycle consisted of 30 seconds of denaturation at 95°C, 30 seconds 
of annealing at a temperature specific for each primer (T able 1) and 45 
seconds of elongation at 72°C. Amplified PCR products were resolved 
by electrophoresis in a 1.5 per cent agarose gel, stained with ethidium 
bromide and viewed under UV transillumination.
A molecular mimic was used to determine the sensitivity of the 
CAV-1, parvovirus and herpesvirus PCRs. Briefly, this was achieved 
by individually cloning the amplified fragment of interest from each of 
these pathogens into the cloning vector pJET1.2 (Fermentas) according 
to the manufacturer’s instructions. Chemically competent Escherichia 
coli cells (One Shot T op10 E coli; Invitrogen) were transformed with 
this construct and plasmid DNA was extracted from E coli grown over-
night in liquid culture (Plasmid mini kit; Qiagen). Plasmid DNA was 
quantified using a spectrofluorescent method (Quant-iT PicoGreen 
dsDNA reagent; Invitrogen). A 10-fold dilution series was made by 
diluting the plasmid DNA in polyinosinic-polycytidylic acid (Poly 
I:C) from 1 x 108 to 1 x 100 copies. Following linearisation of plasmid 
DNA, PCR was performed on each of the standards (methodology 
as previously described) and products evaluated on an agarose gel to 
ascertain the sensitivity of the PCR. The lowest standard plasmid dilu-
tion in which a visible DNA band of the expected size was observed 
was used to determine the sensitivity of each PCR.
The present study also confirmed the ability of the PCR to detect 
CAV-1, parvovirus and Leptospira species in formalin-fixed, paraffin-
embedded liver tissue by performing PCR on DNA extracted from 
such tissues in dogs with natural infections. Specificity was assessed 
in silico for primer pairs for CAV-1, parvovirus and herpesvirus by 
searching the GenBank sequence database, NCBI and, apart from the 
target genes, other sequences of significance were not identified.
Results
Signalment, history, clinical signs and 
physical examination
Sixty-eight cases were identified, 10 of which presented to the QVSH. 
The median age at presentation was three years seven months (range, 
seven months to eight years five months). There were 48 female and 
was performed at the time of diagnosis and included measurement of 
alkaline phosphatase (ALP), alanine aminotransferase (ALT),  aspartate 
aminotransferase (AST), γ-glutamyl aminotransferase (GGT), total 
serum bilirubin (TBIL), albumin, globulin, cholesterol, urea and bile 
acids. Complete blood count (CBC) included a total white blood cell 
count, differential white cell counts and haematocrit. Because not all 
dogs had platelet numbers confirmed by examination of a blood film, 
this parameter was not assessed. Coagulation times included pro-
thrombin time and partial thromboplastin time. Data are presented 
as median (range). Additional information on long-term outcome was 
obtained from the clinical records or via telephone conversation with 
the referring veterinary surgeon or owners. Follow-up times were 
based on a censor dated September 30, 2010.
Liver samples were obtained percutaneously with ultrasound 
guidance and using a Tru-cut biopsy needle (n=35), laparoscopically 
(n=8), via wedge biopsy at exploratory surgery (n=22) or at postmor-
tem examination within 30 minutes of death (n=3). Liver tissue was 
fixed in 10 per cent neutral-buffered formalin and routinely processed 
for histopathological examination. Paraffin-embedded tissue was 
obtained for review by the authors from all dogs presenting at other 
centres. All sections were stained with haematoxylin and eosin, reti-
culin, periodic acid Schiff and rhodanine. Copper accumulation was 
scored on sections with rhodanine stain as zero (absence or rare copper-
positive cells), one (few random copper-positive cells), two (moderate 
numbers of copper-positive cells) and three (many copper-positive cells 
in all zones) using a previously established semiquantitative scoring 
system (Shih and others 2007).
PCR for CAV-1, canine parvovirus, canine herpesvirus and patho-
genic Leptospira species was performed on liver tissue from all dogs. 
Liver tissue was fresh frozen, stored in a commercially available nucleic 
acid preservative (RNAlater; Invitrogen), formalin-fixed or formalin-
fixed, paraffin-embedded. DNA was extracted using a commercially 
available kit (DNeasy blood and tissue kit; Qiagen), according to the 
manufacturer’s instructions with minor adjustments. T o confirm suc-
cessful DNA extraction, a control PCR was performed using primers 
specific for the canine cardiac actin gene (Brouillette and others 2000). 
PCR primers for the detection of CAV-1, parvovirus and herpesvirus 
were designed on conserved regions within genes of a candidate virus 
family. When multiple sequences were available for the same patho-
gen, the conserved parts of the genome were found by aligning the dif-
TABLE 1: Primer sequences
Target Forward primer sequence (5′-3′) Reverse primer sequence (5′-3′) Annealing temperature (°C)
Canine cardiac actin gene AGCACTGTTAGAGACACCTG CGGATAGCACGTTGTTGGCA 57
Canine adenovirus-1 TGCTGCCACAATGGTCTTAC CCACAGTGGGGTTTCTGAAC 60
Canine parvovirus GACTGGGAATCGGAAGTTGA CAATGCCAGCCTTGATCTTT 59
Canine herpesvirus CTCTGGGAGATGCGATTGAT AAACTTCAGGAGCGCTTTCA 59
Pathogenic Leptospira 
species
TGAGTAACACGTGGGTAATCTTCC CAGGTACCATCATCACATYGCTGC 62
TABLE 2: Results of clinical pathology
Parameter (units)
Median 
value
Range of 
values
Reference 
interval
Percentage of cases 
with a value above the 
reference interval
Percentage of cases 
with a value below the 
reference interval
Alkaline phosphatase (iu/l) 821 85-4902 26-107 100 0
Alanine aminotransferase (iu/l) 690 127-2018 14-67 100 0
Aspartate aminotransferase (iu/l) 361 10-1043 12-49 75 3
γ-Glutamyl aminotransferase (iu/l) 26 0-129 0-10 63 N/A
Total bilirubin (μmol/l) 77 9-203 0-12 69 N/A
Albumin (g/l) 22 18-45 25-41 7 38
Globulin (g/l) 38 21-53 24-47 12 7
Cholesterol (mmol/l) 4.4 1.2-12.1 3.3-6.5 35 22
Urea (mmol/l) 6.2 1.8-10.2 2.5-7.4 6 26
Resting bile acids (μmol/l) 87 8-310 0-10 76 N/A
Prothrombin time (seconds) 12.2 7.1-62.8 7.6-11.6 24 2
Partial thromboplastin time (seconds) 31.0 15.0-96.5 12.5-25.5 21 0
Haematocrit (l/l) 0.41 0.27-0.59 0.37-0.55 12 12
White blood cell count (x109/l) 16.1 5.5-36.4 6.0-17.0 77 2
Neutrophil count (x109/l) 12.1 6.3-33.9 3.0-11.5 74 0
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20 male dogs (female:male ratio 2.6:1). Seven of 20 entire female 
dogs were in oestrus or had been in oestrus in the two months before 
  presentation. Four dogs had a prior diagnosis of hypothyroidism 
and were on thyroid replacement medication. T wo dogs had been 
diagnosed with osteoarthritis and were currently being treated with 
non-steroidal anti-inflammatory drugs (NSAIDs). One dog had been 
diagnosed with bacterial pyoderma and was currently being treated 
with cephalexin. T wo dogs had received oral corticosteroids within 
the three months before presentation and one dog had received a topi-
cal corticosteroid preparation. Clinical signs at presentation included 
lethargy (n=63), decreased appetite (n=58), vomiting (n=34), weight 
loss (n=31), diarrhoea (n=21) and polydipsia (n=21). Five dogs were 
asymptomatic at presentation and were investigated only for increas-
es in serum liver enzymes. Abnormalities on physical examination 
included icterus (n=37), hyperthermia (n=24), poor body condition 
(n=23), ascites (n=17) and abdominal pain (n=9).
Clinicopathologic findings
All cases had serum biochemistry and a CBC performed and a concur-
rent smear examination was performed in 57 cases. The clinicopatho-
logic findings in all cases are given in T able 2. ALT and ALP were elevat-
ed in all dogs with median values of 690 and 821 iu/l, respectively. AST 
and GGT were elevated in 75 and 63 per cent of cases with median 
values of 361 and 26 iu/l, respectively. Bilirubin was increased in 69 per 
cent of cases with a median value of 77μmol/l. Albumin and urea, were 
reduced in 38 and 22 per cent of cases, respectively. Resting bile acids 
were increased in 76 per cent of cases with a median value of 87 μmol/l. 
Prothrombin time and partial thromboplastin time were measured in 
49 cases and were increased in 24 and 21 per cent of cases, respectively. 
The median white blood cell count was 16.1 x 109/l and 77 per cent of 
cases had an elevated white blood cell count.
Diagnostic imaging
Thirty-three dogs had lateral or ventrodorsal abdominal radiographs 
taken and of those 27 had reduced liver size and 16 had splenom-
egaly. Sixteen dogs had both a reduced liver size and splenomegaly. 
Ultrasonography was performed in all dogs. The liver appeared small 
in 49 dogs and normal in size in the remainder. Changes in hepatic 
parenchymal echogenicity were present in 62 dogs and included hyp-
oechogenicity (n=12), hyperechogenicity (n=10) or a combination of 
hypo- and hyperechogenicity (n=40) when compared with the echo-
genicity of the spleen. Six dogs had a normal appearance to the liver 
on ultrasound. An abdominal effusion was present in 27 dogs.
Histopathology
CH was diagnosed in all dogs and the predominant inflammatory 
cell type was the lymphocyte, with all dogs having lesser number 
of   plasma cells (Figs 1 and 2). Forty-five dogs also had a neutrophilic 
inflammatory cell infiltrate, but in number, neutrophils were less than 
the lymphocytes. The inflammatory cell infiltrate was present both in 
the portal area and throughout the hepatic parenchyma. Hepatocyte 
necrosis and apoptosis predominantly located in areas of inflamma-
tory cell infiltrate were prominent in all dogs. Hepatocyte vacuolation 
was present in 49 dogs. All dogs had evidence of increased fibrous con-
nective tissue on reticulin staining and 38 dogs had bridging fibrosis 
and of these 22 had cirrhosis. Cases with bridging fibrosis had com-
binations of portal-portal (n=30), portal-central (n=24) and central-
central (n=18). Rhodanine staining for copper was positive in 21 
dogs and this was scored as one in 19 dogs and two in two dogs. The 
distribution of copper was multifocal and excess copper was located 
primarily in the periportal region in all dogs.
PCR for aetiological agents
The sensitivity of each PCR in genome copies per reaction was 1 x 
101 (adenovirus-1), 1 x 101 (parvovirus) and 1 x 102 (herpesvirus). PCR 
amplification of DNA extracted from formalin-fixed, paraffin-em-
bedded liver tissue was positive for CAV-1, parvovirus and Leptospira 
species.
Liver tissue used for DNA extraction consisted of fresh frozen 
(n=15), stored in a commercially available nucleic acid preservative 
(RNAlater; Invitrogen) (n=48), formalin-fixed (n=3) or formalin-
fixed, paraffin-embedded (n=2). After DNA extraction and PCR 
amplification, all liver tissues were positive for the canine cardiac actin 
gene. All positive controls for each PCR reaction were positive, while 
the negative controls were negative. PCR for the identification of 
CAV-1, parvovirus, herpesvirus and pathogenic Leptospira species was 
negative in all cases.
Treatment
Dogs were treated with a variety of medications according to clinician 
preference including ursodeoxycholic acid, prednisolone, antibiotics, 
S-adenosylmethionine, H2 receptor antagonists, antiemetics, lactulose, 
spironolactone and furosemide.
Outcome
The median survival time of all dogs was 189 days (range, 1 to 1211 
days). The median survival time of symptomatic dogs was 171 days 
(range, 1 to 1211 days) and that of asymptomatic dogs was 203 days 
(median 66 to 413 days). Thirty-eight dogs died within three months 
and 12 dogs survived more than a year following diagnosis. Fifteen 
dogs are alive to date. Of the dogs that died, all died or were eutha-
nased due to liver-related complications. There was no clear associa-
tion between treatments and survival time.
FIG 1: Low-power photomicrograph of liver tissue demonstrating 
disruption to the normal architecture by a marked and generalised 
infiltrate of inflammatory cells and also bundles of fibrous tissue 
(arrows). Haematoxylin and eosin. Original magnification x40
FIG 2: High-power photomicrograph of liver tissue demonstrating 
the presence of mononuclear cells including lymphocytes and 
plasma cells (long arrows), an occasional neutrophil (short arrows) 
and apoptotic hepatocyte (arrow head). Hepatocyte vacuolation 
is also present (asterisks). Haematoxylin and eosin. Original 
magnification x400
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Discussion
This study shows that CH occurs in young to middle-aged ESSs and 
there is a female predisposition. A female predisposition to CH has 
also been reported in the dobermann (Crawford and others 1985) and 
labrador retriever (Andersson and Sevelius 1991). We do not know the 
gender distribution of the ESS population in the UK however, and it 
is possible that a female overrepresentation may exist. The majority 
of ESSs presented with non-specific clinical signs, typical of canine 
CH in other breeds (Sevelius 1995, Poldervaart and others 2009). Five 
dogs were asymptomatic, and were investigated for an increase in liver 
enzymes found on routine blood testing for other reasons.
Clinicopathologic findings were consistent with hepatic disease 
and in all dogs included an increase in one or more of the serum 
enzymes ALT, AST, ALP or GGT. T otal bilirubin was increased in 
nearly 70 per cent of dogs concomitant with the physical examination 
finding of jaundice and appears to be a particular feature of CH in the 
ESSs. The percentage of cases showing elevation in total bilirubin is 
higher than that reported in the labrador retriever (Shih and others 
2007), dobermann (Johnson and others 1982) and a variety of other 
breeds with CH (Sevelius 1995). Non-specific indicators of a reduction 
in hepatic function present in some dogs included hypoalbuminaemia 
and decreased urea. The most common ultrasonographic abnormality 
was a change in hepatic echotexture to a combination of hypo- and 
hyperechogenicity, followed by a reduction in hepatic size. The find-
ing of normal hepatic echotexture on ultrasound in some dogs despite 
a histological diagnosis of CH highlights the insensitivity of this 
test for the detection of changes suggestive of CH. Ultrasonographic 
changes were not correlated with histopathological findings but are 
likely non-specific and compatible with several different pathological 
processes (Feeney and others 2008). It therefore appears that the best 
initial screening test for the presence of CH in the ESS is the finding of 
increased serum liver enzymes in a young to middle-aged dog.
Confirmation of the diagnosis of CH requires hepatic histopathol-
ogy. The histological appearance is consistent with standardised cri-
teria for CH developed by the WSAVA Liver Standardization Group 
(Van den Ingh and others 2006). The inflammatory cell infiltrate in 
ESSs was predominantly lymphocytic with lesser number of plasma 
cells, although some cases also had a neutrophilic component to their 
disease. Despite the acute presentation of clinical signs in some dogs, 
all dogs had evidence of hepatic fibrosis on histology. It was also note-
worthy that despite the absence of clinical signs in some dogs, hepatic 
histopathology revealed significant liver disease in all dogs. The pres-
ence of a number of necrotic and apoptotic hepatocytes in areas of 
inflammation appears to be a particular feature of CH in the ESSs. 
Vacuolation of hepatocytes was an additional feature although this 
change is likely non-specific and representative of a variety of hepatic 
insults (Ishak 2000).
The present study failed to identify any aetiological factors for CH 
in the ESSs. The aetiology of CH in the majority of cases of canine 
CH is also unknown, although a proportion of cases are due to disor-
ders of copper metabolism (Poldervaart and others 2009). Disorders 
of copper metabolism have been reported in the Bedlington, Skye 
and West Highland white terriers, dalmatian, dobermann and labra-
dor retriever (Watson 2004). This diagnosis is made by document-
ing increased copper by quantitative analysis, the histological finding 
of copper accumulation in hepatocytes around the central vein and 
response to treatment with copper-chelating drugs (Hultgren and oth-
ers 1986). There was no evidence of significant copper accumulation 
based on semiquantitative histological staining in the present study. 
When present, all but two dogs had only a few copper-laden hepato-
cytes and these were located primarily in the periportal region. The 
two remaining dogs had moderate numbers of copper-laden hepato-
cytes located in a similar region. This pattern of copper accumulation 
is likely secondary to cholestasis as seen in human cholestatic liver 
disease (Owen and others 1977). Quantitative copper analysis was 
not deemed necessary in the present study as there is good correlation 
between the amount of copper visualised by histological staining and 
quantitative measurement (Schultheiss and others 2002, Hoffmann 
and others 2006).
CH in the ESSs shares some of the features of human viral hepa-
titis including a predominantly lymphocytic inflammation, necrosis 
and apoptosis in areas of inflammation and mild to moderate hepa-
tocyte vacuolation (Ishak 2000), suggesting the possibility of the 
involvement of a previously undocumented viral agent. Although 
studies using a candidate virus approach to identify canine hepatitis 
viruses have been unsuccessful (Rakich and others 1986, Chouinard 
and others 1998, Boomkens and others 2005), a transmissible agent 
capable of causing acute CH has been described previously in dogs in 
the UK (Jarrett and O’Neil 1985, Jarrett and others 1987). No further 
work to identify the transmissible hepatitis-causing agent was per-
formed (W. F. Jarrett, personal communication). The investigation for 
potential infectious aetiological agents in the present cases consisted 
of PCR for known hepatotrophic viruses and pathogenic Leptospira 
species. PCR was negative in all dogs, which is in agreement with 
previous studies of CH in a variety of dog breeds (Boomkens and oth-
ers 2005). Although Helicobacter species have been proposed to cause 
CH in some dogs (Fox and others 1996), testing for the presence of 
Helicobacter species was not performed. Helicobacter organisms were not 
visible on histopathological sections viewed under light microscopy, 
although this can be insensitive for diagnosis. More specific histologi-
cal stains for Helicobacter organisms, such as Warthin-Starry, were not 
used.
Primary immune-mediated mechanisms have also been suggested 
to cause canine CH (Andersson and Sevelius 1992, Weiss and others 
1995, Poitout and others 1997, Dyggve and others 2011) but have 
never been conclusively demonstrated. The ESS is predisposed to the 
development of other autoimmune diseases, such as immune-medi-
ated haemolytic anaemia (Reimer and others 1999). The presence 
of concurrent hypothyroidism at the time of diagnosis in four dogs 
raises the possibility of an autoimmune aetiology to CH in this breed, 
although this may be a coincidental finding. The occurrence of oestrus 
or recent oestrus at the time of diagnosis in seven dogs also suggests 
that immunological dysregulation predisposing to the development of 
disease or worsening current disease may be present. In human beings, 
the worsening of autoimmune liver disease occurs in pregnancy due to 
changes in the concentration of oestrogen and progesterone (Candia 
and others 2005), although studies to document the effects of these 
hormones on canine CH have not been performed. Histological fea-
tures such as a predominance of foci of plasma cells and multinucle-
ated hepatocytes characteristic of human autoimmune hepatitis (Ishak 
2000), are however, not typical features of CH in the ESS.
The potential for a toxic aetiology to CH in the ESS exists. Three 
dogs were receiving NSAIDs at the time of diagnosis and these drugs 
have been associated with the development of a hepatopathy in a 
number of dog breeds particularly the labrador retriever (MacPhail and 
others 1998). It is unknown whether the ESS is similarly affected. No 
dog was being treated with other known hepatotoxic drugs, although 
environmental or dietary exposure to potentially hepatotoxic sub-
stances could not be ruled out.
Survival time ranged from 1 to 1211 days, with a median survival 
of 189 days. This compares to a median survival time of 374 days 
(range 1 to 2645 days) in labrador retrievers with CH (Shih and oth-
ers 2007). Previous studies examining survival in different breeds of 
dogs with CH report a mean survival time ranging from 4.1 months 
(Poldervaart and others 2009) to 19 months (Strombeck and others 
1988). Interestingly, the survival time of the asymptomatic dogs in 
this study was similar to that of the symptomatic dogs. No standard-
ised treatment regimen was used in the present study, so it was not 
possible to assess the effects of treatment on survival. In a separate 
study, however, the authors have recently demonstrated that treat-
ment with corticosteroids has no effect on survival in ESSs with CH 
(Shawcroft and others 2010). This is contrary to a previous study that 
reported improved survival in a variety of dog breeds treated with cor-
ticosteroids (Strombeck and others 1988) and might suggest that the 
aetiology of CH in the ESS is not predominantly autoimmune, but 
more studies are necessary to confirm this.
In conclusion, this study documents a breed-related CH that 
occurs in ESSs. The disease should be considered in young to middle-
aged ESSs, which present with increases in liver enzymes, and some 
dogs may be asymptomatic. The diagnosis is confirmed by hepatic 
histopathology in which widespread predominantly lymphocytic 
inflammatory cell infiltrate is seen. Varying degrees of fibrosis and Veterinary Record | October 15, 2011
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other criteria for a diagnosis of CH are also present. The aetiology is 
unknown but the disease does not appear to be related to currently 
known canine hepatotrophic viruses, pathogenic Leptospira species or 
copper accumulation. No specific treatments exist and the disease car-
ries a relatively poor prognosis.
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